Editorial draft — not for publication yet. Tramadol content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.
Quick answer
For neuropathic (nerve) pain in adults, NICE says to consider tramadol only if acute rescue therapy is needed. It says not to start tramadol for long-term neuropathic pain in non-specialist settings unless a specialist advises it.
NICE limits tramadol to acute rescue use in non-specialist care
This is distinct from whether tramadol can ever be used for pain: the recommendation concerns a specific pain type and a specific care setting. A clinician may need to confirm whether symptoms are neuropathic and consider the separate treatment pathway.
Do not change an existing prescription abruptly
If you already take tramadol for nerve pain, NICE guidance is not an instruction to stop it suddenly. Discuss the expected benefit, side effects, duration, and other options with the clinician who knows your case.
If a change is agreed after regular use, ask for a written reduction plan and follow-up. Opioid withdrawal can occur; NICE recommends a gradual, individual approach in most cases.
What to ask at a review
Ask whether the pain is thought to be neuropathic, what tramadol is expected to improve, how long it should be used, and when the treatment will be reviewed. Ask which alternatives or specialist support fit your diagnosis and health history.
Report new weakness, numbness, loss of bladder or bowel control, or rapidly worsening symptoms urgently. Such symptoms may need assessment rather than a change in pain medicine.
A clinician should identify the type of nerve pain
Neuropathic pain is pain caused by a problem in the somatosensory nervous system. People may describe burning, electric-shock sensations, pins and needles, or pain from a normally non-painful touch, but symptoms alone do not confirm the diagnosis.
Assessment considers the history, examination, possible cause, and impact on daily life. The treatment approach for nerve pain differs from general acute pain, which is why NICE gives tramadol a specific, limited role.
NICE lists other initial treatment options
For most neuropathic pain conditions in non-specialist settings, NICE recommends considering a choice of amitriptyline, duloxetine, gabapentin, or pregabalin as initial treatment, with clinical review if one is not effective or tolerated. Tramadol is considered only for acute rescue treatment.
Those medicines have their own side effects and interactions and are not suitable for everyone. Do not start, stop, or combine them with tramadol without a prescriber reviewing the plan.
Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.
Frequently asked questions
Does NICE recommend tramadol for nerve pain?
NICE says to consider it only for acute rescue treatment and not to start it for long-term neuropathic pain in non-specialist settings unless a specialist advises it.
Should I stop tramadol if I take it for nerve pain?
Do not stop a regular prescription suddenly. Arrange a review to discuss the NICE guidance, your response, and a safe plan if treatment changes.
What is acute rescue treatment?
It means short-term treatment for a sudden episode of severe pain, rather than routine long-term use. A clinician should decide whether that applies to you.
What does nerve pain feel like?
People may describe burning, electric-shock pain, pins and needles, or pain from light touch, but a clinician needs to assess the cause.
Sources and further reading
This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.
- NICE: Neuropathic pain in adults: recommendations
- NICE: Medicines associated with dependence or withdrawal: recommendations
- NHS: Tramadol: NHS medicine guide
- electronic Medicines Compendium: Tramadol 50 mg capsules: Summary of Product Characteristics
Editorial status: Editorial draft — clinical review required before publication. Sources checked on 2 October 2026.
Related information
Read the Tramadol overview or continue to another topic: